FIELD: medicine.
SUBSTANCE: phospholipid suspension contains dihydroquercetin, at least one membrane-forming phospholipid, glycine and water solution of ethyl alcohol with 0.05 to 20% of spirit. To produce phospholipid suspension the following should be performed: dihydroquercetin and phospholipid solution in ethyl alcohol and dispersive medium comprising glycine solution in deionised water. Dispersive medium shall be brought to rotation till stable rotation swirl is obtained, then dihydroquercetin solution shall be added to the rotation swirl and the obtained mixture is to be divided into concentrate of disperse phase and disperse medium.
EFFECT: invention enables to increase stability and extend the period of suspension storage, increase bioavailability and selectiveness of active compound exposure.
13 cl, 7 ex
| Title | Year | Author | Number |
|---|---|---|---|
| USE OF PHOSPHOLIPID EMULSION COMPRISING DIHYDROQUERCETIN TO PROTECT DONOR ORGAN TISSUE AND PREVENT ITS REJECTION IN TRANSPLANTOLOGY | 2023 |
|
RU2804132C1 |
| PHARMACEUTICAL COMPOSITION FOR TRANSDERMAL APPLICATION FOR INCREASE OF DRUG ACTIVITY AND DECREASE OF SIDE EFFECTS | 2010 |
|
RU2469706C2 |
| AGENT FOR BURN AND WOUND HEALING | 2011 |
|
RU2470653C2 |
| ANTIOXIDANT LIPOSOMAL COMPOSITION FIR INHALATION IN LUNG AND UPPER RESPIRATORY TRACT DISEASES | 2006 |
|
RU2315593C1 |
| COMPOSITION OF DIHYDROQUERCETINE ENCLOSED IN PHOSPHOLIPID NANOPARTICLES | 2013 |
|
RU2536208C1 |
| MEDICATION FOR TREATMENT OF PSORIASIS | 2009 |
|
RU2424811C2 |
| METHOD FOR PRODUCING LIPOSOMAL AGENT EXHIBITING WOUND HEALING ACTION | 2009 |
|
RU2417075C1 |
| PHARMACEUTICAL COMPOSITION CONTAINING SERPISTEN SUBSTANCE WITH WOUND HEALING EFFECT | 2015 |
|
RU2670090C2 |
| COSMETIC REMEDY FOR REGENERATING FADED SKIN | 1992 |
|
RU2036637C1 |
| GEL FORMULATION (VERSIONS) | 2006 |
|
RU2331407C1 |
